Publication details

Úprava guidelines ACC pro léčbu srdečního selhání v roce 2021

Title in English 2021 ACC update of the heart failure guidelines
Authors

ŠPINAR Jindřich MÁLEK Filip ŠPINAROVÁ Lenka VÍTOVEC Jiří TÁBORSKÝ Miloš LINHART Aleš

Year of publication 2021
Type Article in Periodical
Magazine / Source COR ET VASA
MU Faculty or unit

Faculty of Medicine

Citation
Web https://actavia.e-coretvasa.cz/artkey/cor-202102-0005_2021-acc-update-of-the-heart-failure-guidelines.php
Doi http://dx.doi.org/10.33678/cor.2021.033
Keywords ARNI; Guidelines; Heart failure; SGLT2 inhibitors
Description The American College of Cardiology has published an update of the heart failure guidelines treatment in the beginning of the year 2021. We bring short information about this document. It is expected that the European Society of Cardiology will publish new European guidelines this year, which will probably confirm the increasing indication for sacubitril valsartan (ARNI) and for SGLT2 inhibitors, as a new drug class for heart failure treatment. The percutaneous access for the treatment of mitral regurgitation is also a new one.

You are running an old browser version. We recommend updating your browser to its latest version.

More info